Rockwell Medical
| Company type | Public |
|---|---|
| Nasdaq: RMTI Russell 2000 Index component | |
| Industry | Pharmaceutical industry |
| Founded | 1996 |
| Headquarters | Wixom, Michigan |
Key people | Stuart Paul (president and CEO) Ajay Gupta (CSO) Raymond D. Pratt (CMO) |
| Revenue | $63 million (2018) |
| -$32 million (2018) | |
| Total assets | $52 million (2018) |
| Total equity | $27 million (2018) |
Number of employees | 269 (2018) |
| Website | rockwellmed |
| Footnotes / references | |
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
The company's primary customers are dialysis providers.